Search research articles
Contact Us
Filters
Showing results (61-70 of 93) with videos related to
Page
of 10
Sort By:
Journal of Clinical Pathology
|
June 30, 2009
Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication
M B K Lambros, D S P Tan, R L Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2012
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
A F C Okines, L C Thompson, D Cunningham, et al.
Jornal De Pediatria
|
December 4, 2003
[Krabbe s disease - case report]
L D Noronha, G Sampaio, I Bruck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2025
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives
A Marra, S Morganti, F Pareja, et al.
Oncogene
|
October 4, 2006
BRCA1 dysfunction in sporadic basal-like breast cancer
N C Turner, J S Reis-Filho, A M Russell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C Marchiò, M Scaltriti, M Ladanyi, et al.
The Journal of Pathology
|
November 15, 2006
Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour
R Natrajan, S E Little, N Sodha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S Guiu, S Michiels, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L R Yates, J Seoane, C Le Tourneau, et al.
Oncogene
|
January 27, 2010
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N Turner, M B Lambros, H M Horlings, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 93) with videos related to
Sort By:
Page
of 10
Journal of Clinical Pathology
|
June 30, 2009
Genomic profile of a secretory breast cancer with an ETV6-NTRK3 duplication
M B K Lambros, D S P Tan, R L Jones, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 13, 2012
Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
A F C Okines, L C Thompson, D Cunningham, et al.
Jornal De Pediatria
|
December 4, 2003
[Krabbe s disease - case report]
L D Noronha, G Sampaio, I Bruck, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 30, 2025
Artificial intelligence entering the pathology arena in oncology: current applications and future perspectives
A Marra, S Morganti, F Pareja, et al.
Oncogene
|
October 4, 2006
BRCA1 dysfunction in sporadic basal-like breast cancer
N C Turner, J S Reis-Filho, A M Russell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research
C Marchiò, M Scaltriti, M Ladanyi, et al.
The Journal of Pathology
|
November 15, 2006
Analysis by array CGH of genomic changes associated with the progression or relapse of Wilms' tumour
R Natrajan, S E Little, N Sodha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 21, 2012
Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement
S Guiu, S Michiels, F André, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 16, 2017
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
L R Yates, J Seoane, C Le Tourneau, et al.
Oncogene
|
January 27, 2010
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
N Turner, M B Lambros, H M Horlings, et al.
Page
of 10